These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34082125)

  • 21. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
    Rasmussen JL; Park MA; Fischer PR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene Mutations Linked to Hereditary Angioedema in Solitary Angioedema Patients With Normal C1 Inhibitor.
    Bork K; Wulff K; Witzke G; Staubach P; Hardt J; Meinke P
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2441-2449. PubMed ID: 36787826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor.
    Bork K; Wulff K; Hardt J; Witzke G; Lohse P
    Haemophilia; 2014 Sep; 20(5):e372-5. PubMed ID: 25113305
    [No Abstract]   [Full Text] [Related]  

  • 24. Lanadelumab to treat hereditary angioedema.
    Wedi B
    Drugs Today (Barc); 2019 Jul; 55(7):439-448. PubMed ID: 31347612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lanadelumab for the prevention of attacks in hereditary angioedema.
    Valerieva A; Senter R; Wu MA; Zanichelli A; Cicardi M
    Expert Rev Clin Immunol; 2019 Dec; 15(12):1239-1248. PubMed ID: 31721602
    [No Abstract]   [Full Text] [Related]  

  • 26. Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.
    Yigit M; Sogut O; Lisar H; Yigit E
    Niger J Clin Pract; 2018 Apr; 21(4):531-533. PubMed ID: 29607870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary angioedema].
    Aygören-Pürsün E; Bork K
    Internist (Berl); 2019 Sep; 60(9):987-995. PubMed ID: 31363809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of patients with angioedema without wheals: the importance of F12 gene screening.
    Firinu D; Bafunno V; Vecchione G; Barca MP; Manconi PE; Santacroce R; Margaglione M; Del Giacco SR
    Clin Immunol; 2015 Apr; 157(2):239-48. PubMed ID: 25744496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII).
    Bork K; Wulff K; Witzke G; Hardt J
    Allergy; 2017 Feb; 72(2):320-324. PubMed ID: 27905115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor.
    Bova M; Suffritti C; Bafunno V; Loffredo S; Cordisco G; Del Giacco S; De Pasquale TMA; Firinu D; Margaglione M; Montinaro V; Petraroli A; Radice A; Brussino L; Zanichelli A; Zoli A; Cicardi M
    Allergy; 2020 Jun; 75(6):1394-1403. PubMed ID: 31860755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
    Stehlin F; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema.
    Liu J; Qin J; Borodovsky A; Racie T; Castoreno A; Schlegel M; Maier MA; Zimmerman T; Fitzgerald K; Butler J; Akinc A
    RNA; 2019 Feb; 25(2):255-263. PubMed ID: 30463937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations.
    de Maat S; Björkqvist J; Suffritti C; Wiesenekker CP; Nagtegaal W; Koekman A; van Dooremalen S; Pasterkamp G; de Groot PG; Cicardi M; Renné T; Maas C
    J Allergy Clin Immunol; 2016 Nov; 138(5):1414-1423.e9. PubMed ID: 27130860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of kallikrein inhibitor lanadelumab in hereditary angioedema.
    Hwang G; Johri A; Ng S; Craig T
    Immunotherapy; 2019 Aug; 11(11):937-944. PubMed ID: 31234673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hereditary angioedema].
    Bouchard LJ; Hyry H; Meri S
    Duodecim; 2012; 128(24):2547-54. PubMed ID: 23393928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant C1 esterase inhibitor (Ruconest) for hereditary angioedema.
    Med Lett Drugs Ther; 2016 Mar; 58(1491):e44-5. PubMed ID: 27027690
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the safety and effectiveness of berotralstat for patients with hereditary angioedema: Report of six cases.
    Takamura S; Nakamura K; Fukuda T
    J Dermatol; 2023 Nov; 50(11):1506-1508. PubMed ID: 37721445
    [No Abstract]   [Full Text] [Related]  

  • 39. Hereditary angioedema with F12 mutation: Clinical features and enzyme polymorphisms in 9 Southwestern Spanish families.
    Piñero-Saavedra M; González-Quevedo T; Saenz de San Pedro B; Alcaraz C; Bobadilla-González P; Fernández-Vieira L; Hinojosa B; García-Lozano R
    Ann Allergy Asthma Immunol; 2016 Nov; 117(5):520-526. PubMed ID: 27788882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
    Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
    J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.